- Novus Scientific
-
Novus Scientific (www.novusscientific.com[1]) is an innovator in the development and commercialization of resorbable synthetic medical devices. Global HQ is in Singapore while European Headquarters and the core R&D function are in Uppsala, Sweden.
Novus Scientific was founded in 2008 by the medical device entrepreneur Thomas Engström upon the sale of his previous company Radi Medical Systems AB to the U.S company St. Jude Medical Inc.[2]
The hemostasis division of Radi Medical was responsible for the development of a resorbable polymer seal device used for femoral arterial closure culminating in a product called Femoseal. Other products developed for market by Radi Medical Systems were the Pressurewire and modality known as FFR (Fractional Flow Reserve), FemoStop and RadiStop.
Having initiated R&D and filed the first patent back in 2004, Novus has developed the world's first long-term resorbable synthetic surgical mesh which was cleared for use by the FDA in February 2010 for use in reinforcement of soft tissue where weakness exists. It is being used successfully for numerous surgical repairs including: inguinal hernia, TRAM/DIEP Flap donor site and ventral hernia. Surgical procedures have been performed in the Far East and Europe as well as in the United States.
TIGR® Matrix Surgical Mesh
TIGR® Matrix Surgical Mesh is a 100 percent resorbable, synthetic mesh, knitted from two different resorbable fibers that degrade at different rates following the placement of the mesh. Fiber 1 is strong for 1 – 2 weeks and is completely gone in 4 months. Fiber 2 is strong for 6 – 9 months and is completely gone in 3 years. This allows the body to heal effectively, ideally, forming strong tissue as the mesh is absorbed.
References
External links
Categories:- Medical equipment manufacturers
Wikimedia Foundation. 2010.
